Comparative analysis of brivaracetam and levetiracetam in epilepsy treatment
Epilepsy affects millions of people worldwide, necessitating effective and safe treatment options. Brivaracetam (BRV) and levetiracetam (LEV) are antiepileptic drugs that target the synaptic vesicle protein 2A (SV2A). Despite the similarities in their chemical structure, BRV and LEV exhibit distinct...
Saved in:
| Main Authors: | Ming-Yuan Hsu, Shu-Wei Hu, Hueng-Chuen Fan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| Series: | Tungs’ Medical Journal |
| Subjects: | |
| Online Access: | https://doi.org/10.4103/ETMJ.ETMJ-D-24-00027 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Outcome Analysis in Epilepsy Patients Undergoing Switchover from Levetiracetam to Brivaracetam
by: Agna Maria Rejy, et al.
Published: (2025-01-01) -
The Effect of Treatment for Epilepsy Associated with Malignant Neoplasms of the Brain: a Literature Review
by: Y. Wang, et al.
Published: (2023-12-01) -
Efficacy and tolerability of brivaracetam in the treatment of epilepsy: literature review and own experience
by: O. A. Pylaeva, et al.
Published: (2018-11-01) -
Anaphylaxis to levetiracetam in an adolescent: a very rare occurence
by: Şeyma Kahraman, et al.
Published: (2021-06-01) -
Adjunctive Brivaracetam in People with Epilepsy and Intellectual Disability: Evidence from the BRIVAracetam Add-On First Italian netwoRk Study
by: Simona Lattanzi, et al.
Published: (2025-03-01)